Metabolic reprogramming and immune-metabolic interactions in Respiratory viral infections
Respiratory viruses, including influenza, RSV, and SARS-CoV-2, hijack host metabolic machinery to facilitate their replication and evade immune surveillance. This review synthesizes current evidence on the bidirectional interplay between viral-induced metabolic reprogramming – specifically the upregulation of glycolysis, lipogenesis, and glutaminolysis, and the disruption of mitochondrial homeostasis – and the host immune response. We highlight how this metabolic rewiring not only provides biosynthetic precursors for viral proliferation but also modulates immune cell differentiation and inflammatory outcomes. Furthermore, we discuss how preexisting host metabolic conditions (e.g. obesity, diabetes, aging) exacerbate disease severity through this metabolic-immune axis, and how persistent metabolic alterations may underlie post-acute sequelae such as Long COVID. Finally, we evaluate the therapeutic potential and challenges of targeting metabolic checkpoints, such as mTOR and SREBP, to balance antiviral efficacy with immune homeostasis. PubMed was searched for articles from database inception to July 2026.
Authors
- Yan-ni Bi
- 王明义
- Mengwei Zhang
- Jiahui Cao
- Wei Li
Institutions
- Weifang Medical University (CN)
- Shandong University (CN)
- Dalian Medical University (CN)
Publication Details
- Journal
- Future Virology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1080/17460794.2026.2762771
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00